Warburg to Make Nearly 3x its Money on Bausch & Lomb Sale

Warburg Pincus looks like it will nearly triple its investment once it sells Bausch & Lomb to Valeant Pharmaceuticals.

28 May 2013•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles